Diabetic neuropathy: Mechanisms to management

被引:547
作者
Edwards, James L. [1 ]
Vincent, Andrea M. [1 ]
Cheng, Hsinlin T. [1 ]
Feldman, Eva L. [1 ]
机构
[1] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA
关键词
Diabetic neuropathy; Mitochondria; Oxidative stress; Pain therapy; Bioinformatics;
D O I
10.1016/j.pharmthera.2008.05.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Neuropathy is the most common and debilitating complication of diabetes and results in pain, decreased motility, and amputation. Diabetic neuropathy encompasses a variety of forms whose impact ranges from discomfort to death. Hyperglycemia induces oxidative stress in diabetic neurons and results in activation of multiple biochemical pathways. These activated pathways are a major source of damage and are potential therapeutic targets in diabetic neuropathy. Though therapies are available to alleviate the symptoms of diabetic neuropathy, few options are available to eliminate the root causes. The immense physical, psychological, and economic cost of diabetic neuropathy underscore the need for causally targeted therapies. This review covers the pathology, epidemiology, biochemical pathways, and prevention of diabetic neuropathy, as well as discusses current symptomatic and causal therapies and novel approaches to identify therapeutic targets. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 34
页数:34
相关论文
共 419 条
[1]   Acupuncture for the treatment of chronic painful peripheral diabetic neuropathy: a long-term study [J].
Abuaisha, BB ;
Costanzi, JB ;
Boulton, AJM .
DIABETES RESEARCH AND CLINICAL PRACTICE, 1998, 39 (02) :115-121
[2]   Risk factors for diabetic peripheral sensory neuropathy - Results of the Seattle Prospective Diabetic Foot Study [J].
Adler, AI ;
Boyko, EJ ;
Ahroni, JH ;
Stensel, V ;
Forsberg, RC ;
Smith, DG .
DIABETES CARE, 1997, 20 (07) :1162-1167
[3]  
ADMINISTRATION FAD, 1997, CENT DRUG EVAL RES, P168
[4]   Critical review of oral drug treatments for diabetic neuropathic pain - clinical outcomes based on efficacy and safety data from placebo-controlled and direct comparative studies [J].
Adriaensen, H ;
Plaghki, L ;
Mathieu, C ;
Joffroy, A ;
Vissers, K .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2005, 21 (03) :231-240
[5]   Advanced glycation endproducts - role in pathology of diabetic complications [J].
Ahmed, N .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 67 (01) :3-21
[6]   Inhibition of PKC β by oral administration of ruboxistaurin is well tolerated and ameliorates diabetes-induced retinal hemodynamic abnormalities in patients [J].
Aiello, LP ;
Clermont, A ;
Arora, V ;
Davis, MD ;
Sheetz, MJ ;
Bursell, SE .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2006, 47 (01) :86-92
[7]  
Aiello LP, 2005, DIABETES, V54, P2188
[8]   Hypoglycemic and antioxidant effect of oleuropein in alloxan-diabetic rabbits [J].
Al-Azzawie, HF ;
Alhamdani, MSS .
LIFE SCIENCES, 2006, 78 (12) :1371-1377
[9]   New phosphodiesterase inhibitors in the treatment of erectile dysfunction [J].
Anderson, PCB ;
Gommersall, L ;
Hayne, D ;
Arya, M ;
Patel, HRH .
EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (11) :2241-2249
[10]  
Anjaneyulu Muragundla, 2004, Indian Journal of Experimental Biology, V42, P766